SkinHealth Systems Inc. (SKIN) Gross Margin
- Gross margin · 12 months: Value 66.35%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 66.35% | Gross profit / revenue. Period ending 2026-06-30. $192.45M ÷ $290.05M × 100 ≈ 66.35% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 192.45M USD | Gross Profit |
| Revenue | 290.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $192.45M | $290.05M | (m) | 66.35% |
| 2026-03-31 | $192.22M | $296.12M | (m) | 64.91% |
| 2025-12-31 | $196.36M | $300.79M | (m) | 65.28% |
| 2025-09-30 | $195.67M | $301.92M | (m) | 64.81% |
| 2025-06-30 | $190.69M | $310.06M | (m) | 61.50% |
| 2025-03-31 | $182.51M | $322.47M | (m) | 56.60% |
| 2024-12-31 | $182.30M | $334.29M | (m) | 54.53% |
| 2024-09-30 | $175.64M | $347.62M | (m) | 50.53% |
| 2024-06-30 | $122.43M | $366.23M | (m) | 33.43% |
| 2024-03-31 | $149.37M | $393.12M | (m) | 38.00% |
| 2023-12-31 | $155.11M | $397.99M | (m) | 38.97% |
| 2023-09-30 | $177.48M | $399.30M | (m) | 44.45% |
| 2023-06-30 | $251.40M | $390.68M | (m) | 64.35% |
| 2023-03-31 | $253.56M | $376.74M | (m) | 67.30% |
| 2022-12-31 | $250.34M | $365.88M | (m) | 68.42% |
| 2022-09-30 | $241.93M | $345.63M | (m) | 70.00% |
| 2022-06-30 | $226.43M | $324.99M | (m) | 69.67% |
| 2022-03-31 | $202.02M | $287.96M | (m) | 70.16% |
| 2021-12-31 | $181.83M | $260.09M | (m) | 69.91% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $67.20M | $119.09M | (m) | 56.43% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2019-12-31 | $106.51M | $166.62M | (m) | 63.92% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |